Cyclic nucleotide-induced helical structure activates a TIR immune effector

Nature. 2022 Aug;608(7924):808-812. doi: 10.1038/s41586-022-05070-9. Epub 2022 Aug 10.

Abstract

Cyclic nucleotide signalling is a key component of antiviral defence in all domains of life. Viral detection activates a nucleotide cyclase to generate a second messenger, resulting in activation of effector proteins. This is exemplified by the metazoan cGAS-STING innate immunity pathway1, which originated in bacteria2. These defence systems require a sensor domain to bind the cyclic nucleotide and are often coupled with an effector domain that, when activated, causes cell death by destroying essential biomolecules3. One example is the Toll/interleukin-1 receptor (TIR) domain, which degrades the essential cofactor NAD+ when activated in response to infection in plants and bacteria2,4,5 or during programmed nerve cell death6. Here we show that a bacterial antiviral defence system generates a cyclic tri-adenylate that binds to a TIR-SAVED effector, acting as the 'glue' to allow assembly of an extended superhelical solenoid structure. Adjacent TIR subunits interact to organize and complete a composite active site, allowing NAD+ degradation. Activation requires extended filament formation, both in vitro and in vivo. Our study highlights an example of large-scale molecular assembly controlled by cyclic nucleotides and reveals key details of the mechanism of TIR enzyme activation.

MeSH terms

  • Animals
  • Antiviral Agents / immunology
  • Antiviral Agents / metabolism
  • Bacteria* / immunology
  • Bacteria* / metabolism
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / immunology
  • Bacterial Proteins / metabolism
  • NAD / metabolism
  • Nucleotides, Cyclic* / chemistry
  • Nucleotides, Cyclic* / immunology
  • Nucleotides, Cyclic* / metabolism
  • Receptors, Interleukin-1* / chemistry
  • Receptors, Interleukin-1* / immunology
  • Receptors, Interleukin-1* / metabolism
  • Second Messenger Systems
  • Toll-Like Receptors* / chemistry
  • Toll-Like Receptors* / immunology
  • Toll-Like Receptors* / metabolism

Substances

  • Antiviral Agents
  • Bacterial Proteins
  • Nucleotides, Cyclic
  • Receptors, Interleukin-1
  • Toll-Like Receptors
  • NAD